Cargando…

Cost-effectiveness and accuracy of cervical cancer screening with a high-risk HPV genotyping assay vs a nongenotyping assay in China: an observational cohort study

BACKGROUND: New screening techniques may affect the optimal approaches for the prevention of cervical cancer. We evaluated the cost-effectiveness and accuracy of alternative screening strategies to provide evidence for cervical cancer screening guidelines in China. METHODS: In total, 32,306 women we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Binhua, Chen, Lihua, Lin, Wenyu, Su, Yingying, Mao, Xiaodan, Pan, Diling, Ruan, Guanyu, Xue, Huifeng, Kang, Yafang, Sun, Pengming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453699/ https://www.ncbi.nlm.nih.gov/pubmed/32868973 http://dx.doi.org/10.1186/s12935-020-01512-4

Ejemplares similares

The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China
por: Pan, Diling, et al.
Publicado: (2020)

PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort
por: Kang, Yafang, et al.
Publicado: (2018)

HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
por: Chen, Lihua, et al.
Publicado: (2020)

Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case– control study
por: Dong, Binhua, et al.
Publicado: (2018)

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results
por: Xue, Huifeng, et al.
Publicado: (2021)

Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study
por: Dong, Binhua, et al.
Publicado: (2021)

Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study
por: Sun, Pengming, et al.
Publicado: (2017)

Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis
por: Lin, Wenyu, et al.
Publicado: (2022)

Clinical validation of the Cervista(®) high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study
por: Mao, Xiaodan, et al.
Publicado: (2018)

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
por: Ruan, Guanyu, et al.
Publicado: (2018)

Knowledge and Attitudes Regarding HPV and Vaccination Among Chinese Women Aged 20 to 35 Years in Fujian Province: A Cross-Sectional Study
por: Chen, Lihua, et al.
Publicado: (2018)

Evaluation of Knowledge and Attitude Toward HPV and Vaccination Among Medical Staff, Medical Students, and Community Members in Fujian Province
por: Yu, Chang, et al.
Publicado: (2020)

Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping
por: Kim, Moonsik, et al.
Publicado: (2022)

Prevalence of Human Papillomavirus and Genotype Distribution in Pregnant and Non-Pregnant Women in China
por: Luo, Dandan, et al.
Publicado: (2021)

ADCY7 mRNA Is a Novel Biomarker in HPV Infection and Cervical High-Grade Squamous Lesions or Higher
por: Chen, Lihua, et al.
Publicado: (2023)

An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping
por: Chan, Wai Sing, et al.
Publicado: (2020)

Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay
por: Galati, Luisa, et al.
Publicado: (2022)

Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China
por: Zhang, Qiaoyu, et al.
Publicado: (2020)

A drug screening assay on cancer cells chronically adapted to acidosis
por: Pellegrini, Paola, et al.
Publicado: (2018)

The prevalence of human papillomavirus and bacterial vaginosis among young women in China: a cross-sectional study
por: Lin, Wenyu, et al.
Publicado: (2021)

Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer
por: Mao, XiaoDan, et al.
Publicado: (2019)

Characterisation of bioenergetic pathways and related regulators by multiple assays in human tumour cells
por: Jeney, A., et al.
Publicado: (2016)

A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies
por: Monies, Dorota, et al.
Publicado: (2016)

Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression
por: Mao, Xiaodan, et al.
Publicado: (2022)

CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology
por: Pesic, Aleksandra, et al.
Publicado: (2019)

Cervical Lesion Classification Method Based on Cross-Validation Decision Fusion Method of Vision Transformer and DenseNet
por: Li, Ping, et al.
Publicado: (2022)

Assessment of potential anti-cancer stem cell activity of marine algal compounds using an in vitro mammosphere assay
por: de la Mare, Jo-Anne, et al.
Publicado: (2013)

Variant effect prediction tools assessed using independent, functional assay-based datasets: implications for discovery and diagnostics
por: Mahmood, Khalid, et al.
Publicado: (2017)

Performance of the Xpert HPV assay in women attending for cervical screening
por: Cuzick, Jack, et al.
Publicado: (2015)

Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
por: Obiri-Yeboah, Dorcas, et al.
Publicado: (2017)

Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma
por: Li, Si-wei, et al.
Publicado: (2016)

The Role of Obstetric Factors, miRNA-30d and miRNA-181a in Postpartum Women with Pelvic Organ Prolapse
por: Lin, Wenyu, et al.
Publicado: (2020)

Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation
por: Luo, Xiaodan, et al.
Publicado: (2019)

Comparison of Alinity m HPV and cobas HPV assays on cervical specimens in diverse storage media
por: Jang, Dan, et al.
Publicado: (2021)

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2022)

Erratum to: Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
por: Obiri-Yeboah, Dorcas, et al.
Publicado: (2017)

Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
por: Xu, Lan, et al.
Publicado: (2018)

Chemosensitivity assay in mice prostate tumor: Preliminary report of flow cytometry, DNA fragmentation, ion ratiometric methods of anti-neoplastic drug monitoring
por: Sharma, Rakesh, et al.
Publicado: (2004)

Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2023)

Integrated whole genome microarray analysis and immunohistochemical assay identifies COL11A1, GJB2 and CTRL as predictive biomarkers for pancreatic cancer
por: Sun, Defeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hiht2v9v5n5opaeu6m3b5gvta2